Clinical trial
Study of Inectolizumab Combined With Steroid Hormone Adjustment Strategies in Treatment-naive Patients With Neuromyelitis Optica Spectrum Disease
NCT07159893 is registered in ClinicalTrials.gov with First Affiliated Hospital of Wenzhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Inectolizumab Combined With Steroid Hormone Adjustment Strategies in Treatment-naive Patients With Neuromyelitis Optica Spectrum Disease
- Lead sponsor
- First Affiliated Hospital of Wenzhou Medical University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 30, 2025
- Completion date
- September 30, 2026
- Enrollment
- 25 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.